Randomized Phase II Study of Docetaxel versus Doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Publication | Closed Access

Citations

References

2000

Year

Jaap Verweij, S.M. Lee, W. Ruka, J. Buesa, Robert L. Coleman, Q.G.C.M. van Hoesel, C. Seynaeve, Eugenio Donato Di Paola, M. van Glabbeke, D. Tonelli,

UCL Discovery (University College London)

Docetaxel Versus DoxorubicinBone Sarcoma GroupMalignant DiseaseMedicineCancer ManagementPathologyMolecular OncologyCancer TreatmentCancer Soft TissueOncologyRadiation OncologyCancer ChemotherapyChemotherapyCancer Research